Back to Browse Journals » International Journal of Nephrology and Renovascular Disease » Volume 7

Use of the Tego needlefree connector is associated with reduced incidence of catheter-related bloodstream infections in hemodialysis patients

Authors Brunelli SM, Njord L, Hunt AE, Sibbel SP

Received 31 December 2013

Accepted for publication 13 February 2014

Published 3 April 2014 Volume 2014:7 Pages 131—139


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Steven M Brunelli,1 Levi Njord,2 Abigail E Hunt,1 Scott P Sibbel1

1DaVita Clinical Research®, Minneapolis, MN, USA; 2DaVita HealthCare Partners, Inc, Denver, CO, USA

Background and objectives: Catheter-related bloodstream infections (CRBSIs) are common in hemodialysis patients using central venous catheters, and catheter occlusion also occurs frequently. The Tego needlefree connector was developed to reduce the incidence of these complications; however, existing studies of its effectiveness and safety are limited.
Materials and methods: This retrospective analysis compared outcomes among patients of a large dialysis organization receiving in-center hemodialysis using a central venous catheter with either the Tego connector or standard catheter caps between October 1 and June 30, 2013. Incidence rates for intravenous (IV) antibiotic starts, receipt of an IV antibiotic course, positive blood cultures, mortality, and missed dialysis treatments were calculated, and incidence-rate ratios (IRRs) were estimated using Poisson regression models. Utilization of erythropoiesis-stimulating agents (ESAs) and thrombolytics was described for each patient-month and compared using mixed linear models. Models were run without adjustment, adjusted for covariates that were imbalanced between cohorts, or fully adjusted for all potential confounders.
Results: The analysis comprised 10,652 Tego patients and 6,493 controls. Tego use was independently associated with decreased risk of CRBSI, defined by initiation of IV antibiotics (adjusted IRR 0.92, 95% confidence interval [CI] 0.87–0.97) or initiation of IV antibiotic course (adjusted IRR 0.89, 95% CI 0.84–0.95). Tego use was independently associated with decreased rate of missed dialysis treatments (adjusted IRR 0.98, 95% CI 0.97–1.00); no significant difference between Tego and control cohorts was observed with respect to mortality. Tego use was associated with decreased likelihood of thrombolytic use (adjusted per-month probability of 5.6% versus 6.2% for controls) and lower utilization of ESAs in study months 7–9.
Conclusion: Use of the Tego connector may reduce the risk of CRBSI and result in lower utilization of thrombolytics, antibiotics, and ESAs, as well as fewer missed dialysis treatments.

Keywords: catheter, dialysis, end-stage renal disease, ESA, infection, mortality

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] View Full Text [HTML] 


Other article by this author:

Readers of this article also read:

Efficacy of a reduced pill burden on therapeutic adherence to calcineurin inhibitors in renal transplant recipients: an observational study

Sabbatini M, Garofalo G, Borrelli S, Vitale S, Torino M, Capone D, Russo L, Pisani A, Carrano R, Gallo R, Federico S

Patient Preference and Adherence 2014, 8:73-81

Published Date: 9 January 2014

Meta-analysis of the ocular biocompatibility of a new multipurpose lens care system

Reindel W, Merchea MM, Rah MJ, Zhang L

Clinical Ophthalmology 2013, 7:2051-2056

Published Date: 14 October 2013

Application of magnetically induced hyperthermia in the model protozoan Crithidia fasciculata as a potential therapy against parasitic infections

Grazú V, Silber AM, Moros M, Asín L, Torres TE, Marquina C, Ibarra MR, Goya GF

International Journal of Nanomedicine 2012, 7:5351-5360

Published Date: 8 October 2012

Characterization of drug-release kinetics in trabecular bone from titania nanotube implants

Aw MS, Khalid KA, Gulati K, Atkins GJ, Pivonka P, Findlay DM, Losic D

International Journal of Nanomedicine 2012, 7:4883-4892

Published Date: 12 September 2012

A physical model for the size-dependent cellular uptake of nanoparticles modified with cationic surfactants

Xu A, Yao M, Xu G, Ying J, Ma W, Li B, Jin Y

International Journal of Nanomedicine 2012, 7:3547-3554

Published Date: 10 July 2012

Low molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide delivery

Alameh M, DeJesus D, Jean M, Darras V, Thibault M, Lavertu M, Buschmann MD, Merzouki A

International Journal of Nanomedicine 2012, 7:1399-1414

Published Date: 13 March 2012

Strongyloides stercoralis hyperinfection in a post-renal transplant patient

Issa H, Aljama MA, Al-Salem AH

Clinical and Experimental Gastroenterology 2011, 4:269-271

Published Date: 30 November 2011

Prognostic value of changes in arterial stiffness in men with coronary artery disease

Iana A Orlova, Eradzh Yu Nuraliev, Elena B Yarovaya, et al

Vascular Health and Risk Management 2010, 6:1015-1021

Published Date: 4 November 2010

Cecal perforation with an ascending colon cancer caused by upper gastrointestinal endoscopy

Hiroyuki Miyatani, Yukio Yoshida, Hirokazu Kiyozaki

Therapeutics and Clinical Risk Management 2009, 5:301-303

Published Date: 3 April 2009